Home > Insider Trading > Filing (0001209191-23-020280)

Filing Details

Accession Number:: 0001209191-23-020280
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-21 16:40:40
Reporting Period:: 2023-03-17

Accepted Time:: 2023-03-21 16:40:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184592	C Beth Seidenberg	C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2023-03-17	74,045	$7.12	1,904,369	No	4	P	Indirect	See Footnote
Class A Common Stock	Acquisiton	2023-03-20	15,252	$7.21	1,919,621	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

The shares were purchased as follows: 71,594 shares by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 2,451 shares by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein.
Represents weighted average purchase price. The shares were purchased at prices ranging from $6.96 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Consists of 1,841,337 shares of Class A Common Stock held by KPCB XVI and 63,032 shares of Class A Common Stock held by XVI Founders.
The shares were purchased as follows: 14,747 shares by KPCB XVI and 505 shares by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein.
Represents weighted average purchase price. The shares were purchased at prices ranging from $7.14 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Consists of 1,856,084 shares of Class A Common Stock held by KPCB XVI and 63,537 shares of Class A Common Stock held by XVI Founders.